Jakarta, CNBC Indonesia – Chinese vaccine manufacturer Sinopharm discovers neutralizing antibody against the Delta variant. This the company announced on Wednesday and could be effective for short-term prevention and early treatment of Covid-19 caused by the virus.
The research was led by Yang Xiaoming, Chairman of Sinopharm China National Biotec Group, a subsidiary of Sinopharm. The research team managed to find a monoclonal antibody that could block the increase in the novel coronavirus in the enzyme converting Angiotensin 2.
In its announcement, the company explained that the enzyme attaches to cell membranes and is present in the intestines, kidneys, testes, gallbladder and heart. Antibodies are said to be able to prevent viruses from infecting cells, quoted by the Global Times, Thursday (5/8/2021).
As a therapeutic drug, monoclonal antibodies are expected to have strong effectiveness, significant efficacy and low toxicity. The antibodies are called biological missiles and show excellent efficacy and broad application prospects in the treatment of various diseases.
The application of antibodies, otherwise known as 2BII, can significantly reduce viral lung inflammation. In the latest study, 2BII has very consistent neutralizing activity in the Delta variant, has great application value for short-term prevention and early treatment of Covid-19.
The 2BII clinical application was running in an orderly and as expected, the company said. These antibodies can also be applied as soon as possible in the prevention and control of Covid-19 in China.
The Delta variant is known to have spread to almost many countries in the world. Including in China, which was the location where the Covid-19 virus was first discovered in 2019.
Due to the Delta variant, the country’s daily Covid-19 cases have increased again. The spike occurred in big cities such as Beijing to Wuhan on 20 July.
This comes after the virus was detected from a Russian plane flight in Nanjing, Jiangsu Province. Cases reportedly rose to nearly 500 cases.
On Wednesday (4/8/2021), there were 96 new Covid-19 cases in China. There were 71 cases of local transmission.
(roy/roy)
– .
